Scolaris Content Display Scolaris Content Display

Addition of inhaled anticholinergics to beta2‐agonists for children with acute asthma in hospital

This is not the most recent version

view the current version 31 July 2014

References

Additional references

Camargo 2003

Camargo CA, Emond SD, Boulet L, Gibson PG, Kolbe J, Wagner CW, et al. Emergency Department‐Asthma Plan. Developed at "Asthma Education in the Adult Emergency Department: A Multidisciplinary Consensus Conference". New York, 2001.

Chapman 1996

Chapman K. An international perspective on anticholinergic therapy. American Journal of Medicine 1996;100:2‐4S.

Craven 2001

Craven D, Kercsmar CM, Myers TR, O’Riordan MA, Golonka G, Moore S. Ipratropium bromide plus nebulized albuterol for the treatment of hospitalized children with acute asthma. J Pediatr. 2001;138:51‐58.

GINA 2011

Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. National Heart, Lung and Blood Institute. 2011.

Goggin 2001

Goggin N, Macarthur C, Parkin PC. Randomized trial of the addition of ipratropium bromide to albuterol and corticosteroid therapy in children hospitalized because of an acute asthma exacerbation. Arch Pediatr Adolesc Med 2001;155(12):1329‐1334.

Gross 1988

Gross NJ. Ipratropium Bromide. New England Journal of Medicine 1988;8:486–494.

Higgins 2011

Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated September 2011]. The Cochrane Collaboration, Available from www.cochrane‐handbook.org, 2011.

Karpel 1997

Karpel JP, Aldrich TK, Prezant DJ, Guguchev K, Gaitan‐Salas A, Pathiparti R. Emergency treatment of acute asthma with albuterol metered‐dose inhaler plus holding chamber: how often should treatments be administered?. Chest 1997;112(2):348‐356.

Lord 1999

Lord J, Ducharme FM, Stamp RL, Littlejohns P, Churchill R. Cost effectiveness analysis of inhaled anticholinergics for acute childhood and adolescent asthma. BMJ 1999;319:1470‐1471.

NAEPP 2011

National Asthma education and Prevention Program. NAEPP Expert Panel Report Guidelines for the Diagnosis and Management of Asthma. NIH Publication. National Heart, Lung and Blood Institute edition. 2011.

Plotnick 2008

Plotnick L, Ducharme F. Combined inhaled anticholinergics and beta2‐agonists for intial treatment of acute asthma in children. Cochrane Database of Systematic Reviews 2000, Issue 3. [DOI: 10.1002/14651858.CD000060]

Rechelefsky 2003

Rachelefsky G. Treating exacerbations of asthma in children: the role of systemic corticosteroids. Pediatrics 2003;112(2):382‐397.

RevMan 5.1

Review Manager (RevMan) version 5.1 (computer program). Copenhague. The Nordic Cochrane Center: The Cochrane Collaboration2008.

Rowe 2004

Rowe BH, Edmonds ML, Spooner CH, Diner B, Camargo CA. Corticosteroid therapy for acute asthma. Respir Med 2004;98(4):275‐284.

Sears 1992

Sears MR. Clinical application of beta‐agonists. Practical Allergy and Immunology 1992;7:98‐100.

Silverman 1990

Silverman M. The role of anticholinergic antimuscarinic bronchodilator therapy in children. Lung 1990;168:304‐309.

Svedmyr 1985

Svedmyr N. A beta2‐adrenergic agonist for use in asthma pharmacology, pharmacokinetics, clinical efficacy and adverse effects. Pharmacotherapy 1985;5:109‐126.